Copy Link Print Information

CB-5083

53 Cited Publications
Revisión del cliente

Based on 53 publication(s) in Google Scholar

CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP. CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.90%
  • No. CAS: 1542705-92-9
  • Fòrmula: C24H23N5O2
  • Peso molecular:413.47
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • CB-5083 Chemical Structure
    CB-5083 Chemical Structure
  • Experimental Validation Results for CB-5083
  • Experimental Validation Results for CB-5083
  • Experimental Validation Results for CB-5083
  • Experimental Validation Results for CB-5083
  • Experimental Validation Results for CB-5083
No. CAS: 1542705-92-9
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) CB-5083

More
Customer Validation & Images
WBIn Vivo Efficacy StudyFlow Cytometry
  • WB
  • In Vivo Efficacy Study
  • Flow Cytometry
  • WB
  • WB
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • CB-5083 Chemical Structure
    CB-5083 Chemical Structure
    1/16
  • 1/16

    CB-5083 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Jan 24;10(1):26. [Abstract]

    Customer Validation
     CB-5083 (0-2 μM; 24 h). Immunoblot analysis of the indicated proteins in HCCLM3 cells treated with gradient concentrations of CB-5083 or Vehicle for 24 h.

  • 1/16

    CB-5083 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Jan 24;10(1):26. [Abstract]

    Customer Validation
     CB-5083 (50 mg/kg; oral gavage). Hepa1-6 tumors were dissected from the C57BL/6 mice treated with vehicle, CB-5083, aPD1, or both.

  • 1/16

    CB-5083 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Jan 24;10(1):26. [Abstract]

    Customer Validation
     CB-5083 (50 mg/kg; oral gavage). The percentage of CD8+T cells in Hepa1-6 tumors were measured by flow cytometry analysis.

  • 1/16

    CB-5083 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Dec 12;16(1):11092. [Abstract]

    Customer Validation
     Western blotting analysis of RKIP expression in HeLa cells treated with PA, PA plus CB-5083 (2.5 μM) or Vehicle for 12 hrs.

  • 1/16

    CB-5083 purchased from MedChemExpress. Usage Cited in: Leukemia. 2019 Jul;33(7):1675-1686. [Abstract]

    Customer Validation
     CB-5083 (0-2 μM; 6 h). Jeko-1 and Z138C cells are exposed to the indicated concentrations of CB-5083 and ACY-1215 in the presence or absence of the autophagy inhibitor chloroquine for 6 h and LC3B-II and p62 expression is assessed by immunoblot analysis.

  • CB-5083